Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17DN) CEO Matt Plavan describes to Proactive why the group recently acquired CBD-focused Lief Holdings, LLC and Live Zola, LLC. Plavan says in addition to bringing in a 'significant amount of recurring revenue' he sees synergies within the two groups, including integrating Arcadia' e-commerce expertise, together with Lief's retail footprint.
Arcadia Biosciences describes expected synergies with its recent CBD-focused acquisitions